Stay updated on Safety/Efficacy of NLM-001 in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Safety/Efficacy of NLM-001 in Pancreatic Cancer Clinical Trial page.

Latest updates to the Safety/Efficacy of NLM-001 in Pancreatic Cancer Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.8.1 instead of v3.8.0.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe site footer now lists revision v3.8.0 instead of v3.7.2. The study record information appears unchanged.SummaryDifference0.1%

- Check28 days agoChange DetectedA site-wide NIH notice announces that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition period.SummaryDifference0.7%

- Check35 days agoChange DetectedThe website footer’s release label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check42 days agoChange DetectedThe site revision label in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check63 days agoChange DetectedThe record history now shows a newer site revision (v3.7.0) replacing the previous one (v3.6.6). This reflects a software/interface update rather than changes to the study record itself.SummaryDifference0.1%

Stay in the know with updates to Safety/Efficacy of NLM-001 in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety/Efficacy of NLM-001 in Pancreatic Cancer Clinical Trial page.